메뉴 건너뛰기




Volumn 20, Issue 2, 2014, Pages 103-105

Interleukin 6 blockade for hyperimmunoglobulin d and periodic fever syndrome

Author keywords

hyperimmunoglobulin D and periodic fever syndrome; interleukin 6; tocilizumab

Indexed keywords

C REACTIVE PROTEIN; COLCHICINE; CORTICOSTEROID; ETANERCEPT; IMMUNOGLOBULIN D; INTERLEUKIN 6; PREDNISOLONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TOCILIZUMAB;

EID: 84896716262     PISSN: 10761608     EISSN: 15367355     Source Type: Journal    
DOI: 10.1097/01.RHU.0000442576.41537.de     Document Type: Article
Times cited : (32)

References (15)
  • 1
    • 0033039501 scopus 로고    scopus 로고
    • Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome
    • Drenth JP, Cuisset L, Grateau G, et al. Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. Nat Genet. 1999;22:178-181.
    • (1999) Nat Genet , vol.22 , pp. 178-181
    • Drenth, J.P.1    Cuisset, L.2    Grateau, G.3
  • 2
    • 0029009413 scopus 로고
    • Cytokine activation during attacks of hyperimmunoglobulinemia D and periodic fever syndrome
    • Drenth JP, van Deuren M, van der Ven-Jongerkrijg J, et al. Cytokine activation during attacks of hyperimmunoglobulinemia D and periodic fever syndrome. Blood. 1995;85:3586-3593.
    • (1995) Blood , vol.85 , pp. 3586-3593
    • Drenth, J.P.1    Van Deuren, M.2    Van Der Ven-Jongerkrijg, J.3
  • 3
    • 0028026953 scopus 로고
    • Hyperimmunoglobulinaemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients. International Hyper-IgD Study Group
    • Dreneth JP, Haagsma CJ, van der Meer JW. Hyperimmunoglobulinaemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients. International Hyper-IgD Study Group. Medicine (Baltimore). 1994;73:133-144.
    • (1994) Medicine (Baltimore) , vol.73 , pp. 133-144
    • Dreneth, J.P.1    Haagsma, C.J.2    Van Der Meer, J.W.3
  • 4
    • 58149195381 scopus 로고    scopus 로고
    • Long-term follow up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulin D syndrome
    • van der Hilst JC, Bodar EJ, Barron KS, et al. Long-term follow up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulin D syndrome. Medicine (Baltimore). 2008;87:301-310.
    • (2008) Medicine (Baltimore) , vol.87 , pp. 301-310
    • Van Der Hilst, J.C.1    Bodar, E.J.2    Barron, K.S.3
  • 5
    • 33745052318 scopus 로고    scopus 로고
    • AA amyloidosis complicating hyperimmunoglobulinaemia D with periodic fever syndrome: A report of two cases
    • Lachmann HJ, Goodman HJ, Andrews PA, et al. AA amyloidosis complicating hyperimmunoglobulinaemia D with periodic fever syndrome: a report of two cases. Arthritis Rheum. 2006;54:2010-2014.
    • (2006) Arthritis Rheum , vol.54 , pp. 2010-2014
    • Lachmann, H.J.1    Goodman, H.J.2    Andrews, P.A.3
  • 6
    • 0035079195 scopus 로고    scopus 로고
    • Glucocorticoids but not NSAID abort attacks in hyper-IgD and periodic fever syndrome
    • de Dios Garcia-Diaz J, Alvarez-Blanco MJ. Glucocorticoids but not NSAID abort attacks in hyper-IgD and periodic fever syndrome. J Rheumatol. 2001;28:925-926.
    • (2001) J Rheumatol , vol.28 , pp. 925-926
    • De Dios Garcia-Diaz, J.1    Alvarez-Blanco, M.J.2
  • 7
    • 51549087763 scopus 로고    scopus 로고
    • Hyperimmunoglobulinaemia D and periodic fever syndrome; Treatment with etanercept and follow up
    • Topaloglu R, Ayaz NA, Waterham HR, et al. Hyperimmunoglobulinaemia D and periodic fever syndrome; treatment with etanercept and follow up. Clin Rhematol. 2008; 27:1317-1320.
    • (2008) Clin Rhematol , vol.27 , pp. 1317-1320
    • Topaloglu, R.1    Ayaz, N.A.2    Waterham, H.R.3
  • 8
    • 34948822149 scopus 로고    scopus 로고
    • A patient with hyper IgD syndrome responding to anti-TNF treatment
    • Demirkaya E, Caglar MK, Waterham HR, et al. A patient with hyper IgD syndrome responding to anti-TNF treatment. Clin Rheumatol. 2006;26:1757-1759.
    • (2006) Clin Rheumatol , vol.26 , pp. 1757-1759
    • Demirkaya, E.1    Caglar, M.K.2    Waterham, H.R.3
  • 9
    • 33845807104 scopus 로고    scopus 로고
    • Anakinra is safe and effective in controlling hyperimmunoglobulinaemia D syndromeYassociated febrile crisis
    • Cailliez M, Garaix F, Rousset-Rouviere C, et al. Anakinra is safe and effective in controlling hyperimmunoglobulinaemia D syndromeYassociated febrile crisis. J Inherit Metab Dis. 2006;29:763.
    • (2006) J Inherit Metab Dis , vol.29 , pp. 763
    • Cailliez, M.1    Garaix, F.2    Rousset-Rouviere, C.3
  • 10
    • 11044222893 scopus 로고    scopus 로고
    • Inefficacy of etanercept in a child with hyper-IgD syndrome and periodic fever
    • Marchetti F, Barbi E, Tommasini A, et al. Inefficacy of etanercept in a child with hyper-IgD syndrome and periodic fever. Clin Exp Rheumatol. 2004;22:791-792.
    • (2004) Clin Exp Rheumatol , vol.22 , pp. 791-792
    • Marchetti, F.1    Barbi, E.2    Tommasini, A.3
  • 11
    • 23844552119 scopus 로고    scopus 로고
    • Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: Introducing a vaccine provocation model
    • Bodar EJ, van der Hilst JC, Drenth JP, et al. Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccine provocation model. Neth J Med. 2005;63:260-264.
    • (2005) Neth J Med , vol.63 , pp. 260-264
    • Bodar, E.J.1    Van Der Hilst, J.C.2    Drenth, J.P.3
  • 12
    • 84857115753 scopus 로고    scopus 로고
    • Etanercept and anakinra can prolong febrile episodes in patients with hyperimmunoglobulin D and periodic fever syndrome
    • Shendi HM, Walsh D, Edgar JD. Etanercept and anakinra can prolong febrile episodes in patients with hyperimmunoglobulin D and periodic fever syndrome. Rheum Int. 2012;32:249-251.
    • (2012) Rheum Int , vol.32 , pp. 249-251
    • Shendi, H.M.1    Walsh, D.2    Edgar, J.D.3
  • 13
    • 79953689919 scopus 로고    scopus 로고
    • Role of Interlukin-6 in a patient with tumor necrosis factor receptorYassociated periodic syndrome
    • Vaitla PM, Radford PM, Tighe PJ, et al. Role of Interlukin-6 in a patient with tumor necrosis factor receptorYassociated periodic syndrome. Arthritis Rheum. 2011;63:1151-1155.
    • (2011) Arthritis Rheum , vol.63 , pp. 1151-1155
    • Vaitla, P.M.1    Radford, P.M.2    Tighe, P.J.3
  • 14
    • 67549125131 scopus 로고    scopus 로고
    • Rapid improvement of AA amyloidosis with humanized antiYinterleukin 6 receptor antibody treatment
    • Nishida S, Hagihara K, Shima Y, et al. Rapid improvement of AA amyloidosis with humanized antiYinterleukin 6 receptor antibody treatment. Ann Rheum Dis. 2009;68:1235-1236.
    • (2009) Ann Rheum Dis , vol.68 , pp. 1235-1236
    • Nishida, S.1    Hagihara, K.2    Shima, Y.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.